学术探索
学术期刊
新闻热点
数据分析
智能评审

NEOPTERIN IN CLINICAL-PRACTICE

被引：107
作者：
MULLER, MM
CURTIUS, HC
HEROLD, M
HUBER, CH
机构：
[1] UNIV ZURICH, DEPT PEDIAT, DIV CLIN CHEM, CH-8006 ZURICH, SWITZERLAND
[2] UNIV MAINZ, DEPT HEMATOL 3, MED CLIN, W-6500 MAINZ, GERMANY
来源：
CLINICA CHIMICA ACTA | 1991年 / 201卷 / 1-2期
关键词：
NEOPTERIN; PTERINS; INFLAMMATORY DISEASE; CYTOKINE; INTERFERON;
D O I：
10.1016/0009-8981(91)90019-9
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 16
页数：16
相关论文
共 81 条
[1]   SUCCESSFUL TREATMENT OF METASTATIC RENAL-CELL CARCINOMA WITH A BIOLOGICALLY-ACTIVE DOSE OF RECOMBINANT INTERFERON-GAMMA [J].
AULITZKY, W ;
GASTL, G ;
AULITZKY, WE ;
HEROLD, M ;
KEMMLER, J ;
MULL, B ;
FRICK, J ;
HUBER, C .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) :1875-1884
[2]   INTERFERON-GAMMA FOR THE TREATMENT OF METASTATIC RENAL-CANCER - DOSE-DEPENDENT STIMULATION AND DOWN-REGULATION OF BETA-2 MICROGLOBULIN AND NEOPTERIN RESPONSES [J].
AULITZKY, W ;
GASTL, G ;
AULITZKY, WE ;
NACHBAUR, K ;
LANSKE, B ;
KEMMLER, G ;
FLENER, R ;
FRICK, J ;
HUBER, C .
IMMUNOBIOLOGY, 1987, 176 (1-2) :85-95
[3]  
AULITZKY W, 1985, CANCER-AM CANCER SOC, V55, P1052, DOI 10.1002/1097-0142(19850301)55:5<1052::AID-CNCR2820550521>3.0.CO
[4]  
2-9
[5]   ENHANCED SERUM LEVELS OF BETA-2-MICROGLOBULIN, NEOPTERIN, AND INTERFERON-GAMMA IN PATIENTS TREATED WITH RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA [J].
AULITZKY, WE ;
TILG, H ;
HEROLD, M ;
BERGER, M ;
VOGEL, W ;
JUDMAIER, G ;
GASTL, G ;
MULL, B ;
FLENER, R ;
WIEGELE, J ;
PICHLER, E ;
DENZ, H ;
BOHEIM, E ;
AULITZKY, WK ;
HUBER, C .
JOURNAL OF INTERFERON RESEARCH, 1988, 8 (05) :655-664
[6]  
AULITZKY WE, 1988, CLIN NEPHROL, V29, P248
[7]   BIOSYNTHESIS AND SIGNIFICANCE OF NEOPTERIN IN THE IMMUNE-SYSTEM [J].
BLAU, N ;
SCHOEDON, G ;
CURTIUS, HC .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (04) :603-605
[8]  
BOGNER JR, 1987, 3RD INT AIDS C WASH
[9]   MARKERS FOR PANCREAS-GRAFT REJECTION IN HUMANS [J].
BRATTSTROM, C ;
TYDEN, G ;
REINHOLT, FP ;
BOHMAN, SO ;
BORGSTROM, A ;
BACKMAN, L ;
BOLINDER, J ;
GROTH, CG .
DIABETES, 1989, 38 :57-62
[10]  
CLOUSE KA, 1989, J IMMUNOL, V142, P431
123456789